Abstract
Objective
To investigate expression of steroidogenic enzymes involved in androgen and estrogen synthesis in the stroma of postmenopausal ovaries.
Methods
Ovarian stromal tissue samples were obtained at hysterectomy from postmenopausal women who had hysterectomy and oophorectomy. Tissues were frozen immediately in liquid nitrogen and kept frozen until RNA was extracted. Total RNA was examined by Northern blot analysis using P-labeled cDNA probes encoding human P450 side chain cleavage (P450ssc), P45017oi, and cytochrome P450 aromatase (P450arom). Concentrations of mRNA encoding cytochrome P450ssc, cytochrome P450 17a-hydroxylase (CYP17), and P450arom were determined in the ovarian stroma.
Results
We detected P450ssc mRNA in all postmenopausal ovaries studied. P450ssc mRNA was increased threefold in the ovarian stroma of postmenopausal women with endometrial cancer and endometrial hyperplasia. CYP17 mRNA was detected in the ovarian stroma of all women with endometrial cancer. P450arom mRNA was not detected in the ovaries studied.
Conclusion
Postmenopausal ovaries possess enzymes for initiation of steroidogenesis. Enzymes essential for androgen synthesis were expressed in the ovarian stroma of postmenopausal women with endometrial cancer or hyperplasia. (J Soc Gynecol Investig 2003;10:37–40)
Similar content being viewed by others
References
Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976;42:247–53.
Judd HL, Judd GE, Lucas WE, Yen SSC. Endocrine function of postmenopausal ovary. Concentrations of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020–4.
Mattingly RE, Huang WY. Steroidogenesis of the menopausal and postmenopausal ovary. Am J Obstet Gynecol 1969;103:679–93.
Nagamani M, Hannigan EV, Dillard EA, Dinh TV. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 1986;62:508–12.
Marcus CC. Ovarian cortical stromal hyperplasia and cancer of the endometrium. Obstet Gynecol 1963;21:175–86.
Nagamani M, Hannigan EV, Dinh TV, Stuart CA. Hyperinsulinemia and stroma luteinization of the ovaries in post menopausal women with endometrial cancer. J Clin Endocrinol Metab 1988;67:144–8.
Sommers SC, Meissner WA. Endocrine abnormalities accompanying human endometrial cancer. Cancer 1957;10:516–21.
Feinberg R. The stromal theca cell and postmenopausal endometrial carcinoma. Cancer 1969;24:32–8.
Novak ER, Goldberg B, Jones SG, O’Toole RV. Enzyme histochemistry of the menopausal ovary associated with normal and abnormal endometrium. Am J Obstet Gynecol 1965;93:669–93.
Nagamani M, Stuart CA, Doherty MG. Increased steroid production by the ovarian stromal tissue of postmenopausal women with endometrial cancer. J Clin Endocrinol Metab 1992;74:172–6.
Doody KJ, Lorence MC, Mason JI, Simpson ER. Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpus lutea throughout the menstrual cycle. J Clin Endocrinol Metab 1990;70:1041–5.
Nagamani M, Urban RJ. Increased expression of messenger ribonucleic acid encoding cytoclosomol P450 cholesterol side chain cleavage and P450 17α-hydroxylase enzymes in ovarian hyperthecosis. Fertil Steril 1999;71:328–33.
Nakano R, Shirma K, Yamoto M, Kobayashe M, Nishimori K, Hiraoka J. Binding sites for gonadotropins in human postmenopausal ovaries. Obstet Gynecol 1989;73:196–200.
Peluso JJ, Steger RW, Jaszczak S, Hafez ES. Gonadotropin binding sites in human postmenopausal ovaries. Fertil Steril 1976; 27:789–95.
Jose M, Puche C, Cabero A, Cabero L, Messeguer A. Expression of P450c l7 messenger ribonucleic and in postmenopousal human ovaries. Fertil Steril 1999;71:528–35.
Jackson RL, Dockerty MB. The stein leventhol syndrome: Analysis of 43 cases with special reference to association with endometrial cancer. Am J Obstet Gynecol 1957;73:161–73.
Aiman J, Edman CD, Worley RJ, Vellios F, MacDonald PC. Androgen and estrogen formation in women with ovarian hyperthecosis. Obstet Gynecol 1978;51:1–9.
Mohammed CN, Cardenas A, Villasanta U, Toker C, Ances IG. Hilu cell tumor of the ovary and endometrial carcinoma. Obstet Gynecol 1978;52:486–90.
Hausknecht UR, Gusberg SB. Estrogen metabolism in patients at high risk for endometrial carcinoma. The role of androstenedione as an estrogen precursor in postmenopausal women with endometrial carcinoma. Am J Obstet Gynecol 1973;116:981–4.
Rizkallah TH, Tovel HMM, Kelly WG. Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma. J Clin Endocrinol Metab 1975;40:1045–56.
Judd HL, Lucas WE, Yen SSC. Serum 17β-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 1976;43:272–8.
Tseng L, Mazella J, Mann WT, Chumas J. Estrogen synthesis in normal and malignant human endometrium. J Clin Endocrinol Metab 1982;55:1029–31.
Tseng L, Mazella J, Funt MI, Mann WJ, Stone ML. Preliminary studies of aromatase in human neoplastic endometrium. Obstet Gynecol 1984;63:150–4.
Tseng L, Mazella J, Tseng L. Kenetic studies of human endometrial hydroxy steroid dehydrogenase. J Steroid Biochem 1981;14: 437–42.
Plotz EJ, Wiener M, Stein AA, Hahn BD. Enzyme activities related to steroidogenesis in the postmenopausal ovaries of patients with and without endometrial carcinoma. Am J Obstet Gynecol 1967;99:182–97.
Dowsett M, Cantwell B, Lee A, Jeffcoate SL, Harris AL. Suppressions of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin. J Clin Endocrinol Metab 1988;66:672–7
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grants R01 CA45181 and HD-28393 from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Nagamani, M., Urban, R.J. Expression of Messenger Ribonucleic Acid Encoding Steroidogenic Enzymes in Postmenopausal Ovaries. Reprod. Sci. 10, 37–40 (2003). https://doi.org/10.1016/S1071-5576(02)00190-9
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1071-5576(02)00190-9